Citadel

Investments by market, targeted sectors and preferred funding rounds

Name - Citadel
Web -
Description -
Investor Type -
Preferred rounds -
Location

Investments by industry

biotech - 29%
healthtech - 57%
fintech - 14%

Number of investments: 7

Citadel invested in ElevateBio during a round worth $525,000,000 - 3/15/2021
Citadel invested in Ventyx Biosciences during a round worth $114,000,000 - 3/9/2021
Citadel invested in DTx Pharma during a round worth $100,000,000 - 3/5/2021
Citadel invested in Kalshi during a round worth $30,000,000 - 2/17/2021
Citadel invested in Verve Therapeutics during a round worth $94,000,000 - 1/19/2021
Citadel invested in Affinivax during a round worth $226,000,000 - 1/8/2021
Citadel invested in VectivBio during a round worth $110,000,000 - 10/19/2020